Heparin: all 148 studies that test it
Page 2 of 2. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.
- Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated HeparinStatus unknownNCT02144064Phase 3
- Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in SepsisCompletedNCT02135770Phase 3
- Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary ThromboembolismStatus unknownNCT01956955Phase 4
- Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.Status unknownNCT01924104Phase 3
- Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic StrokeStatus unknownNCT01862978Phase 4
- Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated HeparinCompletedNCT01855516Not applicable
- Citrate Versus Heparin Anticoagulation: Effect on Molecules ClearancesStatus unknownNCT01839578Not applicable
- Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the ProcedureTerminatedNCT01823393Phase 4
- Trial of Nebulized Heparin Versus Placebo for Inhalation TraumaTerminatedNCT01773083Phase 3
- DEDICA (Dose of HEparin During Coronary Angioplasty) TrialStatus unknownNCT01694459Phase 4
- PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (SUBCUTANEOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALSStatus unknownNCT01652638Phase 1
- PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (INTRAVENOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALSStatus unknownNCT01651923Phase 1
- Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO PilotCompletedNCT01648036Phase 2
- Heparin Dose for Radial AngiographyCompletedNCT01634438Phase 4
- Understanding "Heparin Resistance" in Cardiac SurgeryCompletedNCT01598883Phase 1
- Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis TrialStatus unknownNCT01555658Phase 3
- The Effect of Heparin on Inhalation InjuryWithdrawnNCT01454869Phase 3
- Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese PatientsStatus unknownNCT01363193Not applicable
- Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology PatientsSuspendedNCT01356329Phase 3
- Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal FailureStatus unknownNCT01346215Phase 3
- Comparison of Subcutaneous Heparin and Enoxaparin for Deep Venous Thrombosis (DVT) Prophylaxis in Surgical Intensive Care PatientsWithdrawnNCT01325779Not applicable
- Effect of Heparin on Femoral Arterial Sheaths Thrombosis During Diagnostic Coronary AngiographyCompletedNCT01260519Phase 3
- Safety of Heparin in Patients With Septic ShockWithdrawnNCT01234285Phase 2
- The Effect of Heparin in Treatment IVF-ET FailureCompletedNCT01214772Phase 4
- EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of BleedingStatus unknownNCT01084993Phase 4
- Heparin Resistance: Predictors and OutcomesCompletedNCT01044888Not applicable
- Prostacyclin's Effect on Platelet ResponsivenessCompletedNCT00890214Phase 4
- Reduced Dose of Unfractionated Heparin in Patients Undergoing PCICompletedNCT00735280Phase 4
- Sodic Heparin Effectiveness of the Treatment of BurnsWithdrawnNCT00701623Phase 2/3
- Intravenous Heparin as an Adjunct for the Treatment of Anaphylactic Reactions in an Emergency DepartmentWithdrawnNCT00657228Not applicable
- Optimal Heparin Dosing Regimens for Cardiopulmonary BypassCompletedNCT00587444Phase 3
- Effect of Free Fatty Acids (FFA) on Androgen Precursors in WomenCompletedNCT00473603Not applicable
- Antithrombotic Regimens and OutcomeCompletedNCT00448461Phase 4
- Enoxaparin Versus Unfractionated Heparin in PCICompletedNCT00439855Phase 4
- Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing SurgeryCompletedNCT00427310Phase 3
- Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related InfectionWithdrawnNCT00378781Not applicable
- Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary SyndromeCompletedNCT00373451Phase 4
- Palifermin DDI (Drug Drug Interaction)CompletedNCT00361348Phase 1
- Does Thinning the Blood During Surgery Prevent Blood Clots Following Total Knee Replacement SurgeryCompletedNCT00253851Phase 4
- Patients Preference With Self-Injection: The PRISM StudyCompletedNCT00253396Phase 4
- Impact of Heparin on the Need for Mechanical Ventilation in NeonatesStatus unknownNCT00196469Phase 4
- Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin SecretionCompletedNCT00188773Phase 4
- PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)CompletedNCT00182143Phase 3
- The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary InterventionCompletedNCT00133731Phase 2
- Unfractioned Heparin for Treatment of SepsisCompletedNCT00100308Phase 3
- SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary EmbolismCompletedNCT00062803Phase 3
- Study of Heparin Prophylaxis of Hereditary Angioedema ExacerbationsCompletedNCT00004694Not applicable
- Treatment for Blood Clots in the Veins of the LegsCompletedNCT00001713Phase 1